Charles River Laboratories International (CRL) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $1.11.
- Charles River Laboratories International's EPS (Basic) fell 1716.42% to $1.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.52, marking a year-over-year decrease of 11888.2%. This contributed to the annual value of $0.2 for FY2024, which is 9783.81% down from last year.
- Charles River Laboratories International's EPS (Basic) amounted to $1.11 in Q3 2025, which was down 1716.42% from $1.06 recorded in Q2 2025.
- Charles River Laboratories International's 5-year EPS (Basic) high stood at $3.69 for Q4 2022, and its period low was -$4.2 during Q4 2024.
- In the last 5 years, Charles River Laboratories International's EPS (Basic) had a median value of $1.76 in 2021 and averaged $1.55.
- In the last 5 years, Charles River Laboratories International's EPS (Basic) soared by 4959.35% in 2022 and then crashed by 21501.68% in 2024.
- Over the past 5 years, Charles River Laboratories International's EPS (Basic) (Quarter) stood at $2.73 in 2021, then surged by 35.16% to $3.69 in 2022, then decreased by 1.08% to $3.65 in 2023, then tumbled by 215.02% to -$4.2 in 2024, then soared by 126.44% to $1.11 in 2025.
- Its EPS (Basic) stands at $1.11 for Q3 2025, versus $1.06 for Q2 2025 and $0.5 for Q1 2025.